Société des Industries Pharmaceutiques de Tunisie - S.A. Stock
Equities
SIPHA
TN0006670012
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.08 TND | -4.45% | -4.45% | +8.51% |
Sales 2021 * | 9.51M 3.07M | Sales 2022 * | - | Capitalization | 7.34M 2.37M |
---|---|---|---|---|---|
Net income 2021 * | -22M -7.1M | Net income 2022 * | - | EV / Sales 2021 * | 7.14 x |
Net Debt 2021 * | 60.6M 19.56M | Net cash position 2022 * | - 0 | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-0.33
x | P/E ratio 2022 * |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 20.01% |
1 day | -4.45% | ||
1 week | -4.45% | ||
1 month | +4.08% | ||
3 months | +8.80% | ||
6 months | -8.72% | ||
Current year | +8.51% |
Managers | Title | Age | Since |
---|---|---|---|
Anis Klouz
CEO | Chief Executive Officer | - | 17-08-18 |
Emin Cherni
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Anis Klouz
CEO | Chief Executive Officer | - | 17-08-18 |
Wasila Hamami
BRD | Director/Board Member | - | 18-12-31 |
Ridha Saidi
BRD | Director/Board Member | - | 18-12-31 |
1st Jan change | Capi. | |
---|---|---|
+8.51% | 2.37M | |
+42.83% | 750B | |
+34.11% | 606B | |
-5.70% | 356B | |
+18.06% | 326B | |
+4.63% | 286B | |
+17.71% | 246B | |
+10.80% | 213B | |
-3.07% | 213B | |
+2.43% | 167B |
- Stock Market
- Equities
- SIPHA Stock